Concepedia

Publication | Open Access

Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells

DOIFull Paper Access

83

Citations

17

References

2013

Year

Rebeka Sultana, Tarek M.A. Abdel-Fatah, Christina J. Perry, Paul M. Moseley, Nada Albarakti, Vivek Chandra mohan, Claire Seedhouse, Stephen Chan, Srinivasan Madhusudan
PLoS ONE

Abstract

Our data provides evidence that ATR inhibition is suitable for synthetic lethality application and cisplatin chemopotentiation in XRCC1 deficient ovarian cancer cells.

References

YearCitations

Page 1